Tagged: Vaccine

A vaccine will be a game-changer for international travel. But it’s not everything - COVID-19

Guest Author Dec 04, 2020

Adrian Esterman, University of South Australia The United Kingdom yesterday became the first country to approve the Pfizer/BioNTech COVID-19 vaccine for widespread use. Following a review by the country’s drug regulator, the UK government announced it will begin rolling out the vaccine next week. Other countries are likely to follow soon, authorising the Pfizer/BioNTech vaccine and possibly other … Read More

How to read results from COVID vaccine trials like a pro - COVID-19

Guest Author Nov 19, 2020

Adrian Esterman, University of South Australia It’s been a busy week or so for news about COVID vaccines. First we heard preliminary clinical trial results from the Pfizer vaccine, then the Russian Sputnik V vaccine. This week, we heard about the Moderna vaccine. All these results were shared with the media, ahead of being peer reviewed and … Read More

Moderna follows Pfizer with exciting vaccine news – how to read these dramatic developments - COVID-19

Guest Author Nov 17, 2020

Simon Kolstoe, University of Portsmouth It is very exciting to hear another positive story about vaccine trial results – a good vaccine is the most likely way of ending the pandemic. Last week, interim results from Pfizer suggested its vaccine reduces cases of COVID-19 with 90% efficacy. Now Moderna has gone one better, with interim results showing nearly … Read More

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data - COVID-19

Guest Author Nov 12, 2020

Harry Al-Wassiti, Monash University; Colin Pouton, Monash University, and Kylie Quinn, RMIT University German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19. These early results are what is known as an “interim analysis”. It’s an early look at the … Read More

Buying a coronavirus vaccine for everyone on Earth, storing and shipping it, and giving it safely will all be hard and expensive - COVID-19

Guest Author Nov 12, 2020

Nicole Hassoun, Binghamton University, State University of New York Infectious diseases do not respect borders. An estimated 3 billion people in low-income countries across Africa, Asia and Latin America are likely to lack access to a COVID-19 vaccine for years after it becomes available. In poor nations, many communities lack the health care workers needed to administer vaccines, … Read More

A new study suggests coronavirus antibodies fade over time – but how concerned should we be? - COVID-19

Guest Author Oct 28, 2020

Sheena Cruickshank, University of Manchester Newly released research suggests that levels of antibodies against the coronavirus have declined across the UK population since testing began. Having randomly sampled 365,000 people across the country, the React2 study – which is yet to be peer-reviewed – estimates that 6% of the UK population had antibodies against the virus … Read More

Coronavirus: the road to vaccine roll-out is always bumpy, as 20th-century pandemics show - COVID-19

Guest Author Sep 26, 2020

Samantha Vanderslott, University of Oxford If you have been following the media coverage of the new vaccines in development for COVID-19, it will be clear that the stakes are high. Very few vaccine trials in history have attracted so much attention, perhaps since polio in the mid-20th century. A now largely forgotten chapter, summer polio outbreaks invoked terror in parents. Read More

From adenoviruses to RNA: the pros and cons of different COVID vaccine technologies - COVID-19

Guest Author Sep 18, 2020

Suresh Mahalingam, Griffith University and Adam Taylor, Griffith University The World Health Organisation lists about 180 COVID-19 vaccines being developed around the world. Each vaccine aims to use a slightly different approach to prepare your immune system to recognise and fight SARS-CoV-2, the virus that causes COVID-19. However, we can group these technologies into five main types. Some technology … Read More

Five things we know about COVID-19, and five we don’t - COVID-19

Robert Hickson Sep 11, 2020

Five things we’ve learnt 1. We know where the virus ultimately came from We know that the virus originally came from bats, and most probably a species of horseshoe bat in South East Asia. However, the spike protein in SARS-CoV-2, which allows the virus to attach to cells and infect them, is more different than those from horseshoe bat … Read More